Physician profile
Judith Brown
NPI 1376923748
$12,447.71
in general payments reported to CMS, 2019-2025
35 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,166 · 2020: $3,904 · 2021: $425 · 2022: $4,342 · 2023: $714 · 2024: $687 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,208.84 | 2019-2022 | |
| Boston Scientific Corporation | $850.10 | 2019-2020 | |
| Hologic Sales and Service, LLC | $572.72 | 2021-2025 | Aptima, Coolseal Generator, Acessa Provu System |
| Abbvie INC. | $513.04 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $315.65 | 2022-2025 | |
| Organon LLC | $291.58 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $219.67 | 2023-2025 | |
| Myovant Sciences INC. | $135.47 | 2021-2022 | |
| Aspira Women'S Health INC | $134.72 | 2022-2024 | Ova1 |
| Agile Therapeutics, INC. | $107.36 | 2021-2024 | Twirla |
| Merck Sharp & Dohme LLC | $106.53 | 2020-2025 | Gardasil, Gardasil 9 |
| Therapeuticsmd, INC. | $104.35 | 2020-2022 | |
| Astellas Pharma US INC | $97.02 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $85.84 | 2023-2025 | Slynd |
| Pfizer INC. | $79.51 | 2022-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $79.11 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $75.63 | 2021-2023 | Balcoltra |
| Amgen INC. | $59.30 | 2022-2023 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $50.34 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $41.54 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $39.20 | 2024-2025 | |
| Biogen, INC. | $38.86 | 2024-2025 | Zurzuvae |
| Conmed Corporation | $29.41 | 2022 | |
| Kerecis Limited | $26.17 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Hologic INC | $24.00 | 2021 | |
| Allergan, INC. | $23.10 | 2019-2020 | |
| Mimedx Group, INC. | $19.13 | 2025 | |
| Smith+Nephew, INC. | $18.25 | 2025 | "Acticoat 4"" X 4""", Pico 7 |
| Pacira Pharmaceuticals Incorporated | $17.47 | 2024 | Exparel |
| Gynesonics, INC. | $15.67 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Nevro Corp. | $15.66 | 2019 | |
| Meditrina | $14.34 | 2023 | |
| Evofem Biosciences, INC. | $13.34 | 2022 | |
| Exact Sciences Corporation | $13.01 | 2023 | Cologuard Collection Kit |
| Dysis Medical, INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.